Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
CAPSULE
**RECOMMENDED DOSAGE** Adult: 1–2 capsules of 15 mg a day before breakfast. Adult: 1 capsule of 30 mg a day before breakfast.
ORAL
Medical Information
**INDICATIONS** For short term use as an adjunct to the treatment of some patients with moderate to severe obesity.
**CONTRAINDICATIONS** Epilepsy; hypersensitivity to sympathomimetic amines; advanced arteriosclerosis; severe hypertension; children under 12 years; hyperexcitability; patients with cardiovascular disease; hyperthyroidism; glaucoma. Patients with a history of drug abuse. During or 14 days following administration of monoamine oxidase inhibitors.
A08AA01
phentermine
Manufacturer Information
EURODRUG LABORATORIES SINGAPORE PTE. LTD.
OSMOPHARM SA
Tjoapack Netherlands B.V (Primary Packager)
Active Ingredients
Documents
Package Inserts
Panbesy PI.pdf
Approved: September 29, 2020